These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11544217)

  • 1. Extragenic suppressors of growth defects in msbB Salmonella.
    Murray SR; Bermudes D; de Felipe KS; Low KB
    J Bacteriol; 2001 Oct; 183(19):5554-61. PubMed ID: 11544217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hot spot for a large deletion in the 18- to 19-centisome region confers a multiple phenotype in Salmonella enterica serovar Typhimurium strain ATCC 14028.
    Murray SR; de Felipe KS; Obuchowski PL; Pike J; Bermudes D; Low KB
    J Bacteriol; 2004 Dec; 186(24):8516-23. PubMed ID: 15576802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. msbB deletion confers acute sensitivity to CO2 in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwf.
    Karsten V; Murray SR; Pike J; Troy K; Ittensohn M; Kondradzhyan M; Low KB; Bermudes D
    BMC Microbiol; 2009 Aug; 9():170. PubMed ID: 19689794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB.
    Clementz T; Zhou Z; Raetz CR
    J Biol Chem; 1997 Apr; 272(16):10353-60. PubMed ID: 9099672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine.
    Murray SR; Ernst RK; Bermudes D; Miller SI; Low KB
    J Bacteriol; 2007 Jul; 189(14):5161-9. PubMed ID: 17449614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant.
    Kong Q; Six DA; Liu Q; Gu L; Roland KL; Raetz CR; Curtiss R
    Infect Immun; 2011 Dec; 79(12):5027-38. PubMed ID: 21930761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the rugose phenotype in waaG and ddhC mutants of Salmonella enterica serovar Typhimurium DT104 is associated with inverse production of curli and cellulose.
    Anriany Y; Sahu SN; Wessels KR; McCann LM; Joseph SW
    Appl Environ Microbiol; 2006 Jul; 72(7):5002-12. PubMed ID: 16820499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.
    Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):289-301. PubMed ID: 15616308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection.
    Fadl AA; Sha J; Klimpel GR; Olano JP; Niesel DW; Chopra AK
    Infect Immun; 2005 Feb; 73(2):1081-96. PubMed ID: 15664952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli msbB gene as a virulence factor and a therapeutic target.
    Somerville JE; Cassiano L; Darveau RP
    Infect Immun; 1999 Dec; 67(12):6583-90. PubMed ID: 10569778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Analysis of Suppressor Mutations in Tumor-Targeted msbB Salmonella.
    Low KB; Murray SR; Pawelek J; Bermudes D
    Methods Mol Biol; 2016; 1409():95-123. PubMed ID: 26846806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Salmonella enterica serovar Typhimurium genes associated with growth suppression in stationary-phase nutrient broth cultures and in the chicken intestine.
    Rychlik I; Martin G; Methner U; Lovell M; Cardova L; Sebkova A; Sevcik M; Damborsky J; Barrow PA
    Arch Microbiol; 2002 Dec; 178(6):411-20. PubMed ID: 12420160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant.
    Lee SR; Kim SH; Jeong KJ; Kim KS; Kim YH; Kim SJ; Kim E; Kim JW; Chang KT
    J Microbiol Biotechnol; 2009 Oct; 19(10):1271-9. PubMed ID: 19884791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
    Somerville JE; Cassiano L; Bainbridge B; Cunningham MD; Darveau RP
    J Clin Invest; 1996 Jan; 97(2):359-65. PubMed ID: 8567955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines.
    Liu T; König R; Sha J; Agar SL; Tseng CT; Klimpel GR; Chopra AK
    Microb Pathog; 2008 Mar; 44(3):224-37. PubMed ID: 17997275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of DeltarelA strains of Escherichia coli and Salmonella enterica serovar Typhimurium suggests a role for ppGpp in attenuation regulation of branched-chain amino acid biosynthesis.
    Tedin K; Norel F
    J Bacteriol; 2001 Nov; 183(21):6184-96. PubMed ID: 11591661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lethal role for lipid A in Salmonella infections.
    Khan SA; Everest P; Servos S; Foxwell N; Zähringer U; Brade H; Rietschel ET; Dougan G; Charles IG; Maskell DJ
    Mol Microbiol; 1998 Jul; 29(2):571-9. PubMed ID: 9720873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of trehalose in growth at high temperature of Salmonella enterica serovar Typhimurium.
    Cánovas D; Fletcher SA; Hayashi M; Csonka LN
    J Bacteriol; 2001 Jun; 183(11):3365-71. PubMed ID: 11344144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella enterica serovar typhimurium resistance to bile: identification and characterization of the tolQRA cluster.
    Prouty AM; Van Velkinburgh JC; Gunn JS
    J Bacteriol; 2002 Mar; 184(5):1270-6. PubMed ID: 11844755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
    Cunningham C; Nemunaitis J
    Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.